{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T19:39:33Z","timestamp":1781206773123,"version":"3.54.1"},"reference-count":31,"publisher":"Informa UK Limited","issue":"11","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Hematology"],"published-print":{"date-parts":[[2023,11,2]]},"DOI":"10.1080\/17474086.2023.2271170","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T10:33:25Z","timestamp":1697193205000},"page":"803-806","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":11,"title":["Redefining efficacy and safety endpoints for chronic lymphocytic leukemia in the era of targeted therapy"],"prefix":"10.1080","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2795-6507","authenticated-orcid":false,"given":"Stefano","family":"Molica","sequence":"first","affiliation":[{"name":"Queens Centre for Oncology and Haematology, Castle Hill Hospital, Hull University NHS Trust, Hull, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,10,16]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509388"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1817073"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1812836"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30788-5"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25638"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006434"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2695"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01485-x"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00293-5"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01210"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2211582"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000840"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1713976"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1815281"},{"key":"e_1_3_3_17_1","doi-asserted-by":"crossref","unstructured":"Kater A Harrup R Kipps TM et al. Final 7-year follow-up and retreatment substudy analysis of MURANO: venetoclax-rituximab (venr)-treated patients with relapsed\/refractory chronic lymphocytic leukemia (R\/R CLL). Oral abstract #S201. European Hematology Association 2023 Congress. Jun 9 2023 Frankfurt DE.","DOI":"10.1097\/01.HS9.0000967716.49281.3f"},{"key":"e_1_3_3_18_1","doi-asserted-by":"crossref","unstructured":"Al-Sawaf O Robrecht S Zhang C et al. Venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: 6-year results of the randomized CLL14 study. Oral abstract #S145. European Hematology Association 2023 Congress. Jun 9 2023 Frankfurt DE","DOI":"10.1097\/01.HS9.0000843484.72409.00"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023020974"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-148308"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14785"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37648-w"},{"key":"e_1_3_3_23_1","doi-asserted-by":"crossref","unstructured":"Kipps T Owen C Flinn IW et al. Long-term outcomes with continuous ibrutinib in patients with CLL: analysis of time to progression. Poster 627. European Hematology Association 2023 Congress. Jun 9 2023 Frankfurt DE","DOI":"10.1097\/01.HS9.0000969412.43267.61"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2023-0436"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.4172\/ebmp.1000e111"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(18)30051-6"},{"key":"e_1_3_3_27_1","unstructured":"https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm#ctc_60"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01342-x"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022018818"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-147112"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13943"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2019-0523"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.06.002"}],"container-title":["Expert Review of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17474086.2023.2271170","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T14:24:43Z","timestamp":1727187883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17474086.2023.2271170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,16]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11,2]]}},"alternative-id":["10.1080\/17474086.2023.2271170"],"URL":"https:\/\/doi.org\/10.1080\/17474086.2023.2271170","relation":{},"ISSN":["1747-4086","1747-4094"],"issn-type":[{"value":"1747-4086","type":"print"},{"value":"1747-4094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,16]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-09-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}